About 1,360 results
Open links in new tab
  1. Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) extended ...

    See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.

  2. Tardive Dyskinesia Treatment Resources - AUSTEDO XR

    Find resources including downloadable guides, patient support and more with AUSTEDO XR® extended release tablets for Tardive Dyskinesia (TD). See safety info and Boxed Warning.

  3. Austedo (deutetrabenazine): Uses, Side Effects, Interactions ... - WebMD

    Jun 26, 2024 · Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

  4. Austedo (Deutetrabenazine): Uses & Side Effects - Cleveland Clinic

    Austedo is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington's disease.

  5. Austedo (Deutetrabenazine): Uses, Dosage, Side Effects, Cost, and ...

    3 days ago · Introduction Austedo is a prescription medication approved by the US Food and Drug Administration for the treatment of involuntary movement disorders, specifically chorea associated …

  6. Austedo (deutetrabenazine): Uses, Side Effects, Dosage & More - GoodRx

    Jun 17, 2025 · Learn about Austedo (deutetrabenazine) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

  7. Deutetrabenazine (Austedo) | NAMI

    Deutetrabenazine is a medication used to decrease the frequency and severity of involuntary, uncontrollable muscle movements that are related to a condition known as Tardive Dyskinesia (TD).

  8. Medications That Can Cause Tardive Dyskinesia: What to Know

    Tardive dyskinesia is a medication-induced condition that causes uncontrolled and repetitive body movements. Changing the medication may help manage the condition. In some cases, a doctor may …

  9. Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

    Jul 28, 2025 · Key Takeaways Tardive dyskinesia results from chronic dopamine-receptor blockade, causing involuntary movements, primarily in the oral-buccal-lingual areas. VMAT2 inhibitors, …

  10. Latest Treatments for Tardive Dyskinesia - HealthCentral

    Mar 24, 2025 · Medically Reviewed Tardive Dyskinesia Treatments You Need to Know Experts explain effective approaches to combat symptoms of this neurological disorder.